Viewing nowCombinationBesilsartan Tablets 10/50 mg (Amlodipine, Losartan Potassium)
Amlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 201502640 · Approved 2015.04.30 · Insurance code 670607230
Treatment of essential hypertension and stage 2 hypertension
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by amlodipine or losartan alone. It is also used as an initial treatment in cases where combination therapy is required to reach the target blood pressure in patients with stage 2 hypertension. Therefore, it helps improve blood pressure control and prevent hypertension-related complications.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Taking this medication during pregnancy may result in several dangerous symptoms, including reduced fetal kidney function, low blood pressure, cranial formation abnormalities, and pulmonary developmental issues. If unavoidable use is required early in pregnancy, the fetal health status should be periodically monitored via ultrasound or other means, and the medication should be stopped if any abnormal symptoms are found. Patients with decreased intravascular effective blood volume, such as those taking diuretics, should be cautious as hypotension may occur upon initiation of this medication. This medication should not be used in patients who are allergic to its components or similar medications, pregnant women or women of childbearing potential, breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, or patients in shock. Caution is also warranted in patients with low blood volume or those on strict salt restriction, those with severe kidney dysfunction or on dialysis, and patients with hyperkalemia. Neurological symptoms such as dizziness, drowsiness, headache may occur while taking this medication, so operating high-risk machinery or driving should be avoided. If there are abnormalities in liver or kidney function, consult a doctor for appropriate dosage adjustment before taking this medication. When taken with other antihypertensive drugs, caution is advised as blood pressure may become too low, and grapefruit juice may enhance the effects, so it is best to avoid it. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned or confirmed, they should inform their healthcare provider immediately. Safety and efficacy in children and adolescents under 18 years have not been established, so its use is not recommended. In case of overdose, severe hypotension or heart rhythm abnormalities may occur, so appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of reach of children and should not be transferred to other containers to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.
Light pink rectangular film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Amlodipine Besylate 13.888mg · Losartan Potassium 50mg
Prescription medication · Combination
Hanpavis Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.